Fineotex Chemical Ltd (FCL) — shareholding pattern, promoter holding, financials and share price

About Fineotex Chemical Ltd (FCL)

Fineotex Chemical Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as FCL and on the BSE under scrip code 533333. Its ISIN is INE045J01034.

Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries [1]

Fineotex Chemical Limited is an Indian-origin specialty performance chemicals manufacturer and solutions provider producing tailor-made formulations across textiles, FMCG cleaning & hygiene, water treatment and oilfield chemicals, with manufacturing campuses in India, Malaysia and newly-additive U.S. facilities, focused on sustainable chemistries, technical services and export-led growth into developed markets.

The company materially strengthened its oilfield and water-treatment capability by acquiring a controlling stake in CrudeChem Technologies Group in December 2025, adding two U.S. plants, an advanced R&D lab, a ~80,000 MTPA manufacturing platform and established marquee clients, which the company expects to be EPS accretive and drive international revenue expansion.

Listed peers in Specialty Chemicals: Laxmi Organic Industries Ltd, Epigral Ltd, Vishnu Chemicals Ltd, Styrenix Performance Materials Ltd, Foseco India Ltd, Yasho Industries Ltd.

Valuation & Returns

10 Jul 2026

At ₹36.91 a share on 10 Jul 2026, Fineotex Chemical Ltd (FCL) was valued at a price-to-earnings ratio of 34.38x and a price-to-book of 5.88x on a book value of ₹6.28 per share as of Mar 2025. Solomo computes return on equity of 17.1% and return on capital employed of 21.1% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
34.38x
P/B
5.88x
EPS (TTM)
₹1.07
Book value / share
₹6.28
ROE
17.1%
ROCE
21.1%
ROA
15.35%
Debt / equity
0x
Dividend yield
3.25%
EBITDA margin
21.73%
52-week range
₹18.98 – ₹47.13

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Fineotex Chemical Ltd (FCL) reported revenue of ₹772 crore, net profit of ₹125 crore and earnings per share of ₹0.93. That compares with revenue of ₹533 crore and net profit of ₹109 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹314 crore and net profit ₹44 crore (consolidated).

Consolidated annual results for Fineotex Chemical Ltd (FCL), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)368517569533772
Net profit (₹ cr)5790121109125
EPS (₹)0.50.81.080.940.93
Compound annual growth for Fineotex Chemical Ltd (FCL). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth21.64%27.80%20.65%-6.26%
Profit growth22.96%55.26%30.27%-9.76%
Stock price CAGR30%32%11%37%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 62.3% of Fineotex Chemical Ltd (FCL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 3.16% and domestic institutional investors (DII) hold 1.36%. Market capitalisation was ₹4,298 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2011.

Largest disclosed public shareholders in Jun 2026: ASHISH KACHOLIA 2.06%, NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND 1.27%, SURESH KUMAR AGARWAL 1.2%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202662.3%-3.16%1.36%37.7%
Mar 202662.3%-2.92%1.27%37.7%
Dec 202562.57%-2.52%1.28%37.43%
Sep 202562.88%-2.34%1.63%37.12%
Jun 202562.88%-2.51%3.17%37.12%
Mar 202562.88%-2.84%3.71%37.12%
Dec 202462.86%-3.36%3.61%37.14%
Sep 202462.88%-3.28%3.63%37.12%
Every quarter since Mar 2011 Filing data, not investment advice.